A look at past incidents reported at U.S. Steel's Clairton Coke Works
A flaring and fire at the Clairton plant in February sent two people to the hospital.
U.S. Steel said that a heating and cooling failure in one of the plant's batteries resulted in a buildup of flammable materials that ignited and caused the boom.
Leaders called it a rare occurrence and the impacted battery was taken off line.
In February of 2024, there were process and equipment failures at seven of the facility's ovens, prompting the health department to get involved, fining U.S. Steel nearly $2 million.
Two years earlier, the Allegheny County Health Department issued an order against U.S. Steel for pushing coke out of ovens without air pollution devices.
In 2018, a catastrophic Christmas Eve fire blamed a failing pipe that led to gas from the ovens igniting.
In 2010, at least 20 people were hurt when an explosion occurred during maintenance work.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today
Key Points Weight loss drugs are big news, and Viking has one in development in both injectable and oral form. Investors are eagerly awaiting trial results later this year. 10 stocks we like better than Viking Therapeutics › Viking Therapeutics (NASDAQ: VKTX) investors have seen a handsome return over the past three years, and this demonstrates that the real battle over biopharmaceutical stocks is won in the lab and clinical trials. Viking Therapeutics doesn't have a commercial product on the market yet and has never generated a dollar in revenue. Yet, it's made many investors wealthy. One thousand dollars invested three years ago is now worth an incredible $10,640 as of Aug. 11. Viking Therapeutics: The best may be yet to come The excitement around the stock centers on its lead development compound, VK2735. It's a GLP-1/GIP dual agonist for the treatment of obesity. Vikings VK2735 is following in the footsteps of Eli Lilly's GLP-1/GIP dual agonist tirzepatide (branded as Zepbound), and investors are hoping VK2735 can achieve similar levels of success. Where is this promising drug now VK2735 is in phase 3 trials in subcutaneous (injection) form, with results probably not due until 2027, and, arguably more excitingly, it's in phase 2 trials in an oral form. The latter has obvious benefits of convenience and comfort for patients, and management expects to report on the phase 2 trial this year. Investors have high hopes, as the phase 2 subcutaneous trial resulted in up to 88% of patients experiencing more than 10% weight loss. The phase 1 trials in oral form were also impressive (remember that phase 1 trials are fundamentally exploratory and often aim to understand safety and tolerability), with a mean weight loss of 8.2% after 28 days of dosing. These results are enough to encourage Viking investors that VK2735 could prove to be a hugely successful compound, and the results of the latest tests of the oral form are eagerly anticipated, not least by potential larger pharmaceutical companies that may try to buy the company and take VK2735 (oral) through phase 3. Should you invest $1,000 in Viking Therapeutics right now? Before you buy stock in Viking Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Viking Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 11, 2025 Lee Samaha has no position in any of the stocks mentioned. The Motley Fool recommends Viking Therapeutics. The Motley Fool has a disclosure policy. If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today was originally published by The Motley Fool
Yahoo
2 minutes ago
- Yahoo
Bausch Health (BHC) Rebounds 15.8% on Bargain-Hunting
We recently published . Bausch Health Companies Inc. (NYSE:BHC) is one of the best-performing stocks on Monday. Bausch Health bounced back by 15.83 percent on Monday to close at $6.66 apiece as investors appeared to have hunted for bargains, having traded below the $6 level for seven days in a row. Monday's share price marked Bausch Health Companies Inc. (NYSE:BHC) first official claw back to the green territory since the start of the month after hovering for most of the trading days below the $5.89 closing price on July 31. It picked up to $5.94 on August 5, but only by a slight 0.85-percent gain from July 31's closing price. Year-to-date, the company's shares were down by 17.4 percent. In recent news, Bausch Health Companies Inc. (NYSE:BHC) expanded its attributable net income by 1,380 percent in the second quarter of the year to $148 million from only $10 million in the same period last year. Revenues also grew by 5 percent to $2.53 billion from $2.4 billion. Copyright: nimon / 123RF Stock Photo For the full-year period, Bausch Health Companies Inc. (NYSE:BHC) raised its revenue guidance to $10 billion to $10.25 billion, as compared with the $9.95 billion to $10.2 billion previously. While we acknowledge the potential of BHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CBS News
4 minutes ago
- CBS News
Nurses at Anaheim hospital hold 1-day strike to voice concerns about employee turnover
Registered nurses at an Orange County hospital are holding a one-day strike on Tuesday, claiming that management has refused to address concerns related to high nurse turnover. The nursing staff at West Anaheim Medical Center said in a news release that it wants a new contract to improve conditions for safe patient care, provide ways to attract new nurses and retain them, and keep up on legal requirements on nurse-to-patient ratios. "Our emergency department is often completely full with a large lobby of patients waiting to be seen," said Liz Rivera, RN in the telemetry unit. "Having a strong, experienced, well-trained workforce in all units will make a huge difference in getting our patients timely and critical care throughout the hospital." Heather Foy, a nurse in the intensive care unit, said the hospital perpetually hires new graduates, who leave for other opportunities quickly after completing their training. "In my twelve years at WAMC, nurse retention has not been this dire. We are truly exhausted and need real solutions," she said. In a statement, WAMC said it has already implemented pay increases for nursing staff that went into effect last week, and its latest proposal in contract negotiations provides benefits it calls among the best in the nation. "We value our employees and their dedication to caring for our community, and in turn, we are committed to ensuring that our mission endures," the statement reads. "West Anaheim Medical Center continues to be a trusted source for healthcare in Orange County, receiving national patient safety and quality recognitions while providing vital care for its community, including A-grades in patient safety, health equity, community benefit, and clinical outcomes from the Lown Institute Hospitals Index. None of this would have been possible without our dedicated staff. We are committed to ensuring a workplace that honors their work and continues to provide lifesaving care." WAMC said the strike will not disrupt patient care. The nurses said negotiations have been ongoing since February and have included three days with a federal mediator. It's not yet clear when the sides will return to the bargaining table. Aerial footage on Tuesday morning showed a large group of nurses gathered outside of the hospital in solidarity. The nurses are expected to return to work on Wednesday.
